Tetra Bio-Pharma Inc. Stock Toronto S.E.
Equities
TBP
CA88166Y1007
Pharmaceuticals
Sales 2020 | - | Sales 2021 | - | Capitalization | 88.81M 121M |
---|---|---|---|---|---|
Net income 2020 | -26M -35.53M | Net income 2021 | -52M -71.06M | EV / Sales 2020 | - |
Net cash position 2020 | 501K 684K | Net cash position 2021 | 1.77M 2.42M | EV / Sales 2021 | - |
P/E ratio 2020 |
-1.86
x | P/E ratio 2021 |
-1.7
x | Employees | 33 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.01% |
Managers | Title | Age | Since |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 16-05-31 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 16-05-31 |
Catherine Auld
BRD | Director/Board Member | - | 21-05-27 |
H. Norton
CHM | Chairman | 63 | 20-09-16 |
1st Jan change | Capi. | |
---|---|---|
+38.28% | 6.07B | |
-16.91% | 4.42B | |
+5.14% | 3.26B | |
-14.63% | 3B | |
-4.12% | 2.47B | |
+42.14% | 1.89B | |
-10.63% | 1.63B | |
-2.71% | 1.6B | |
-12.26% | 1.54B |